Treatment of Posterior Oropharyngeal Cobblestoning

Initial Management Approach

The American Gastroenterological Association recommends initiating empiric therapy with a proton pump inhibitor (PPI) at twice-daily dosing for 2-4 months, combined with dietary and lifestyle modifications, for patients with posterior oropharyngeal cobblestoning suspected to be from GERD or LPR 1, 2
Twice-daily PPI therapy normalizes esophageal acid exposure in 93-99% of GERD patients, ensuring adequate acid suppression, as suggested by the American College of Gastroenterology 2
Single daily dosing is insufficient for extraesophageal manifestations of GERD, according to the American College of Gastroenterology 2
The American Thoracic Society recommends limiting dietary fat to no more than 45 grams per 24 hours, eliminating coffee, tea, soda, chocolate, mints, citrus products, and alcohol, smoking cessation, and avoiding vigorous exercise that increases intra-abdominal pressure, as part of lifestyle modifications 3

The American Academy of Otolaryngology-Head and Neck Surgery suggests that laryngoscopic findings are unreliable for diagnosing LPR and should not be required before initiating treatment, with poor sensitivity and specificity (<50%) and substantial inter- and intra-observer variability 4, 5

If symptoms persist after an adequate trial of twice-daily PPI therapy, the American College of Gastroenterology recommends considering objective testing with 24-hour esophageal pH monitoring or pH-impedance monitoring, while on therapy, to assess for ongoing acid or non-acid reflux 1, 3
The American Thoracic Society suggests adding prokinetic therapy to the PPI regimen, ensuring strict adherence to dietary restrictions, and addressing comorbid conditions that may worsen reflux, if reflux is confirmed but symptoms persist 3

The American College of Gastroenterology recommends that laparoscopic fundoplication should only be considered in patients who have demonstrated clear improvement with PPI therapy, and lack of response to PPI therapy predicts lack of response to anti-reflux surgery 1
The American Academy of Otolaryngology-Head and Neck Surgery explicitly recommends against prescribing antireflux medications for isolated dysphonia or throat symptoms based on laryngoscopic findings alone without visualization confirming other pathology, in their 2018 guidelines 6

Improvement on PPI therapy may result from mechanisms other than acid suppression, such as placebo effect or anti-inflammatory effects, and should not be regarded as definitive confirmation of GERD, as suggested by the American College of Gastroenterology 1
The American College of Gastroenterology recommends considering alternative diagnoses, such as functional laryngeal disorders, laryngeal hypersensitivity, post-nasal drip, allergic rhinitis, and chronic sinusitis, if no response to intensive medical therapy occurs 1, 5

The American Thoracic Society recommends assessing response to therapy within 1-3 months, with most therapeutic trials using 3-4 months of twice-daily PPI therapy before declaring treatment failure 2, 3